J

Jacobson Pharma Corporation Ltd
HKEX:2633

Watchlist Manager
Jacobson Pharma Corporation Ltd
HKEX:2633
Watchlist
Price: 1.29 HKD -0.77% Market Closed
Market Cap: 2.6B HKD

Jacobson Pharma Corporation Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Jacobson Pharma Corporation Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
J
Jacobson Pharma Corporation Ltd
HKEX:2633
Operating Income
HK$432.7m
CAGR 3-Years
21%
CAGR 5-Years
7%
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Operating Income
HK$2B
CAGR 3-Years
-9%
CAGR 5-Years
6%
CAGR 10-Years
19%
U
United Laboratories International Holdings Ltd
HKEX:3933
Operating Income
ÂĄ3.6B
CAGR 3-Years
39%
CAGR 5-Years
24%
CAGR 10-Years
16%
Sino Biopharmaceutical Ltd
HKEX:1177
Operating Income
ÂĄ5.3B
CAGR 3-Years
-12%
CAGR 5-Years
0%
CAGR 10-Years
10%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Operating Income
HK$12.8B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Operating Income
-$19.7m
CAGR 3-Years
58%
CAGR 5-Years
34%
CAGR 10-Years
3%
No Stocks Found

Jacobson Pharma Corporation Ltd
Glance View

Market Cap
2.6B HKD
Industry
Pharmaceuticals

Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors. The company employs 1,723 full-time employees The company went IPO on 2016-09-21. The firm runs its business via two segments. Generic Drugs segment develops, manufactures and distributes a host of off-patent medicine for various therapeutic uses. Currently the activities in this regard are primarily carried out in Hong Kong. Proprietary Chinese Medicines segment develops, manufactures and distributes Chinese medicines. Currently the activities in this regard are primarily carried out in Hong Kong.

Intrinsic Value
2.27 HKD
Undervaluation 43%
Intrinsic Value
Price
J

See Also

What is Jacobson Pharma Corporation Ltd's Operating Income?
Operating Income
432.7m HKD

Based on the financial report for Mar 31, 2025, Jacobson Pharma Corporation Ltd's Operating Income amounts to 432.7m HKD.

What is Jacobson Pharma Corporation Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
7%

Over the last year, the Operating Income growth was 39%. The average annual Operating Income growth rates for Jacobson Pharma Corporation Ltd have been 21% over the past three years , 7% over the past five years .

Back to Top